Table 1.
Site 1 | Site 2 | Site 3 | Site 4 | Total | ||
---|---|---|---|---|---|---|
ESRD pathway stage a | Pre-renal replacement therapy | 3 | 3 | 2 | 0 | 8 |
Dialysis < 2 years | 3 | 2 | 0 | 4 | 9 | |
Dialysis 2+ years | 1 | 8 | 5 | 1 | 15 | |
Transplant | 5 | 8 | 0 | 1 | 14 | |
Gender | Male | 6 | 12 | 5 | 5 | 28 |
Female | 5 | 9 | 2 | 2 | 18 | |
Age group | Under 50 | 2 | 7 | 0 | 1 | 10 |
50–69 | 4 | 9 | 5 | 4 | 22 | |
70+ | 5 | 5 | 2 | 2 | 14 | |
Ethnicity | White | 7 | 17 | 4 | 5 | 33 |
Black and minority ethnic | 4 | 4 | 3 | 2 | 13 | |
Dialysis type | Hospital haemodialysis | 4 | 9 | 2 | 4 | 19 |
Home haemodialysis | 0 | 1 | 3 | 0 | 4 | |
Peritoneal dialysis | 0 | 0 | 0 | 1 | 1 | |
TOTAL | 12 | 21 | 7 | 6 | 46 |
a 46 patients interviewed out of 346 classified as having mild to moderate distress; 346 patients had mild to moderate distress out of 1040 survey respondents; 1040 surveys were returned from 3730 eligible patients surveyed